TMCnet News
Oxford Biomedica Solutions to Present Company Capabilities and its Platform at American Society of Gene and Cell Therapy in Los AngelesBEDFORD, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Oxford Biomedica Solutions LLC, offers The Full Solution™ services, which includes end-to-end development and manufacturing capabilities. The scientific team uses an innovative approach to develop and produce Adeno-Associated Virus (AAV) vectors used in gene therapy. Oxford Biomedica Solutions will be presenting on its industry leading capabilities, including its platform ability to achieve high titers of >1E15 vg/L and >E17 vg of Drug Substance from a single 500L bioreactor at an upcoming Industry conference. “With our current productivity levels, we are now moving to a more economically viable gene therapy model. This allows us to address the broader therapeutic indications, which is critical to our industry and patients,” said Tim Kelly, CEO of Oxford Biomedica Solutions. American Society of Gene & Cell Therapy (ASGCT) The Oxford Biomedica Solutions platform has demonstrated performance of >1E15 vg/L titer, greater than 90% fully intact vector, formulation stability at 2-80C, and consistency across hundreds of constructs and all serotypes tested. A sampling of the technical breadth and capability will be shared at the upcoming ASGCT conference, located at the Los Angeles Convention Center on May 16th -20th, 2023. Symposiums: Industry Sponsored Symposium on May 17th from 12:00 – 1:30pm Exhibitor Showcase on May 17th from 3:45 – 4:15pm Oral Abstract Presentations Title: Ahead of the Game– A scalable purification AEX platform capable of achieving < 10% empty capsids Title: Development of a novel plug-and-play upstream process offering scalable, high-yield production of high-quality AAV vectors Title: Formulate for Success: Early Investment in Drug Product Development Enables Platform Stabilization of Multiple AAV Serotypes, Refrigerated Supply Chain, and Accelerated Dosing Timelines Poster Presentations Date: Thursday May 18, 2023 Date: Friday May 19, 2023 Contact: About Oxford Biomedica Solutions |